Skip to main content
Molecular Therapy. Nucleic Acids logoLink to Molecular Therapy. Nucleic Acids
. 2024 Apr 17;35(2):102188. doi: 10.1016/j.omtn.2024.102188

Retraction Notice to: circRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 sponge

Di Wu, Anliang Xia, Tianlong Fan, Guoqiang Li
PMCID: PMC11044040  PMID: 38665219

Main text

(Molecular Therapy: Nucleic Acids 23, 13–26; March 2021)

This article has been retracted at the request of the editor-in-chief. Concerns regarding image recycling were posted to a Pubpeer thread (https://pubpeer.com/publications/520F477679F345A5AA73A5593BB910). Similarities were found between images in this article and another article in this same journal, Molecular Therapy Nucleic Acids (Ye et al., 2020, Mol. Ther. Nucleic Acids 19, 741–750. https://doi.org/10.1016/j.omtn.2019.12.014). Image analysis performed by the editorial office confirmed the findings of image reuse with Figure 4C. This reuse of data without appropriate attribution represents a severe abuse of the scientific publishing system. The notice of retraction was undeliverable to co-author Tianlong Fan. No response was received from the other authors.


Articles from Molecular Therapy. Nucleic Acids are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES